Type Whole antibody Target TRAIL-R2 CAS Number 845816-02-6 | Source Human ATC code none ChemSpider none | |
Lexatumumab (also known as ETR2-ST01) is an experimental agonistic human monoclonal antibody against TRAIL-R2 (DR5, APO-2) undergoing clinical trials for the treatment of cancer.
HGS-ETR2 antibodies were generated by HGS through a collaboration with Cambridge Antibody Technology.
References
Lexatumumab Wikipedia(Text) CC BY-SA